These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28067691)

  • 1. Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma.
    Watanabe T; Kurata T; Sano K; Suzuki S; Kaneko T; Motobayashi M; Shigemura T; Sumi T; Koike K; Nakazawa Y
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):154-156. PubMed ID: 28067691
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
    Chuman H
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1331-9. PubMed ID: 15446552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P; Angiolillo A; Krailo M; Cheung YK; Anderson B; Davenport V; Reaman G; Cairo MS
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
    Saeter G; Talle K; Solheim OP
    Cancer Chemother Pharmacol; 1995; 36(2):172-5. PubMed ID: 7539339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
    Pápai Z; Bodoky G; Szántó J; Poller I; Rahóty P; Eckhardt S; Láng I; Szendroi M
    Cancer; 2000 Jul; 89(1):177-80. PubMed ID: 10897015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
    Lafay-Cousin L; Lindzon G; Taylor MD; Hader W; Hawkins C; Nordal R; Laperriere N; Laughlin S; Bouffet E; Bartels U
    J Neurosurg Pediatr; 2016 Mar; 17(3):298-302. PubMed ID: 26588458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the combination of ifosfamide and etoposide in the treatment of soft tissue sarcomas.
    Yalçin S
    Oncology; 1999; 57(2):175. PubMed ID: 10461067
    [No Abstract]   [Full Text] [Related]  

  • 10. A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
    Westermann AM; Wiedemann GJ; Jager E; Jager D; Katschinski DM; Knuth A; Vörde Sive Vörding PZ; Van Dijk JD; Finet J; Neumann A; Longo W; Bakhshandeh A; Tiggelaar CL; Gillis W; Bailey H; Peters SO; Robins HI;
    Oncology; 2003; 64(4):312-21. PubMed ID: 12759526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
    Boros L; Garrow GC; Asbury RF; Chang AY
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):28-31. PubMed ID: 7610396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease.
    Schöffski P; Cornillie J; Wozniak A; Li H; Hompes D
    Oncol Res Treat; 2014; 37(6):355-62. PubMed ID: 24903768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide in soft tissue sarcoma.
    Zaidi SH; Iqbal Z; Mallick JA
    J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
    Klingebiel T; Boos J; Beske F; Hallmen E; Int-Veen C; Dantonello T; Treuner J; Gadner H; Marky I; Kazanowska B; Koscielniak E
    Pediatr Blood Cancer; 2008 Apr; 50(4):739-45. PubMed ID: 18286501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
    Klingebiel T; Pertl U; Hess CF; Jürgens H; Koscielniak E; Pötter R; van Heek-Romanowski R; Rossi R; Schött C; Spaar HJ; Willnow U; Treuner J
    Med Pediatr Oncol; 1998 May; 30(5):269-75. PubMed ID: 9544222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
    Cairo MS
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):23-7. PubMed ID: 7610395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
    Wiedemann GJ; Robins HI; Gutsche S; Mentzel M; Deeken M; Katschinski DM; Eleftheriadis S; Crahé R; Weiss C; Storer B; Wagner T
    Eur J Cancer; 1996 May; 32A(5):888-92. PubMed ID: 9081372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of carboplatin and etoposide selective intra-arterial chemotherapy for progressive soft-tissue sarcoma].
    Hamana T; Takahashi M; Miyagi N
    Gan To Kagaku Ryoho; 2000 May; 27(5):729-34. PubMed ID: 10832442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
    Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.
    Fields KK; Elfenbein GJ; Saleh RA; Zorsky PE; Janssen WE; Perkins JB; Saleh TG; Piazza JT; Kronish LE; Machak MC
    Hematol Oncol; 1992; 10(1):61-74. PubMed ID: 1563705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.